oxybutynin has been researched along with tolterodine tartrate in 186 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (3.76) | 18.2507 |
| 2000's | 133 (71.51) | 29.6817 |
| 2010's | 40 (21.51) | 24.3611 |
| 2020's | 6 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, KE; Gillberg, PG; Nilvebrant, L; Sparf, B; Stahl, M | 1 |
| Appell, RA | 3 |
| Balfour, JA; Hills, CJ; Winter, SA | 1 |
| Abrams, P; Anderström, C; Freeman, R; Mattiasson, A | 1 |
| Inadome, A; Kikukawa, H; Seshita, H; Takahashi, W; Ueda, S; Wada, Y; Yono, M; Yoshida, M | 1 |
| Guay, DR | 1 |
| Appell, RA; Drutz, HP; Gleason, D; Klimberg, I; Radomski, S | 1 |
| Chapple, CR | 1 |
| Anderson, MJ; Benson, SR; Guay, DR; Lawrence, M | 1 |
| Doi, T; Ikeura, Y; Imai, S; Kamo, I; Natsugari, H; Okanishi, S | 1 |
| Doi, T; Imai, S; Kamo, I; Okanishi, S | 1 |
| Arikian, SR; Casciano, J; Casciano, RN; Doyle, JJ; Tarride, JE | 1 |
| Appell, RA; Dmochowski, RR | 1 |
| Lemack, GE | 1 |
| Daniels, DV; Eglen, RM; Ford, AP; Hegde, SS; Meloy, TD | 1 |
| Albrecht, D; Anderson, R; Appell, RA; Boone, T; Dmochowski, R; Lama, D; Miklos, J; Roach, M; Saltzstein, D; Sand, P; Staskin, DR; Zinner, N | 1 |
| Anand, C; Malone-Lee, J; Powell, C; Shaffu, B | 1 |
| Nilvebrant, L | 1 |
| Appell, RA; Chancellor, MB; Gupta, SK; Sathyan, G | 1 |
| Dimpfel, W; Todorova, A; Vonderheid-Guth, B | 1 |
| Baker, K; Harvey, MA; Wells, GA | 1 |
| Hartnett, NM; Saver, BG | 1 |
| Rovner, ES; Wein, AJ | 3 |
| Hall, JA; Meyer, JW; Nelson, MA; Wagner, S; Williamson, T | 1 |
| Weiss, BD | 1 |
| Nelson, D; Rackley, R; Wein, A | 1 |
| Crandall, C | 1 |
| Blonski, J | 1 |
| Bernard, L; Goeree, R; O'Brien, BJ; Rosner, A; Williamson, T | 1 |
| Slagle, M | 1 |
| Cannon, TW; Chancellor, MB | 1 |
| Rickwood, AM | 1 |
| Starr, CH | 1 |
| Kosier, JH; Newton, M; Smith, D | 1 |
| Chapple, CR; Nilvebrant, L | 1 |
| Choo, MS; Chung, DY; Hong, JY; Kwon, HY; Lee, JG; Lee, JY; Lee, KS; Lee, T | 1 |
| Burrows, LJ; Garely, AD | 1 |
| Newman, DK | 1 |
| Cheon, C; Chung, KH; Lau, J; Leung, HY; Liu, YS; Wong, HK; Yip, SK | 1 |
| Garely, A; Sussman, D | 1 |
| Appell, RA; Boone, TB; Lai, HH | 1 |
| Giovannini, D; Newman, DK | 1 |
| Averbeck, B; Bräter, M; Ravens, U; Reif, S; Wüst, M | 1 |
| Aslan, AR; Kogan, BA | 1 |
| Cafiero, M; Maloney, CM | 1 |
| Staskin, DR | 1 |
| Crocker, J; Reinberg, Y; Vandersteen, D; Wolpert, J | 1 |
| Bägli, DJ; Bolduc, S; Farhat, W; Khoury, AE; McLorie, GA; Payton, J; Upadhyay, J | 1 |
| Hader, C; Keller, T; Welz-Barth, A | 1 |
| Davila, GW; Dmochowski, RR; Gittelman, MC; Sand, PK; Sanders, SW; Zinner, NR | 1 |
| Ellsworth, P | 1 |
| Elliott, DS; Richelson, E | 1 |
| Appell, RA; Diokno, AC; Dmochowski, RR; Gburek, BM; Kell, SH; Klimberg, IW; Sand, PK | 1 |
| Bang, LM; Easthope, SE; Perry, CM | 1 |
| Homma, Y; Kawabe, K; Lee, JG; Paick, JS | 1 |
| MacDiarmid, SA | 1 |
| Ikeda, K; Kobayashi, S; Miyata, K | 1 |
| Smith, DA | 1 |
| Caro, JJ; El-Hadi, W; Getsios, D; Ishak, KJ; Payne, K | 1 |
| Homma, Y; Uemura, S | 1 |
| Hatanaka, T; Ikeda, K; Kobayashi, S; Miyata, K; Ohtake, A; Sasamata, M; Sato, S; Ukai, M | 1 |
| Homma, Y; Kawabe, K | 1 |
| Bard, RJ; Casey, AR; Ethans, KD; Nance, PW; Schryvers, OI | 1 |
| Rovner, ES | 1 |
| Dubois, D; Hughes, DA | 1 |
| Appell, RA; Dmochowski, RR; Guo, C; Gupta, SK; Sathyan, G | 1 |
| Sand, PK | 1 |
| Athanasopoulos, A; Barbalias, G; Giannitsas, K; Gyftopoulos, K; Nikiforidis, G; Perimenis, P | 1 |
| Wagenlehner, FM | 1 |
| Arold, G; Diefenbach, K; Haselmann, J; Roots, I; Schwantes, U; Wollny, A | 1 |
| Chancellor, MB; de Miguel, F; Kim, Y; Masuda, H; Yoshimura, N | 2 |
| Akkaya, E; Akman, S; Baykara, M; Danisman, A; Guntekin, E; Kukul, E; Yucel, S | 1 |
| Dmochowski, RR; Rosenberg, MT | 1 |
| Aeron, S; Bruhaspathy, M; Chugh, A; Gupta, JB; Gupta, S; Hegde, LH; Kaur, K; Kumar, N; Mehta, A; Sarma, PK; Shetty, SJ; Silamkoti, AD | 1 |
| Altan-Yaycioglu, R; Aydin Akova, Y; Guvel, S; Ozkardes, H; Yaycioglu, O | 1 |
| Anderson, RU; Chu, FM; Dmochowski, RR; Lama, DJ; Sand, PK | 1 |
| Machado, C; Singh-Franco, D; Tuteja, S; Zapantis, A | 1 |
| Gray, M | 1 |
| Chen, A; Dmochowski, R; Gidwani, S; Gupta, S; MacDiarmid, S; Sathyan, G | 1 |
| Ellis, G; Hay-Smith, J; Herbison, P; Morris, A | 1 |
| Armstrong, RB; Luber, KM; Peters, KM | 1 |
| Blume, S; Gu, A; Jumadilova, Z; Shaya, FT; Zyczynski, T | 1 |
| Bavendam, T; Darkow, T; Frytak, JR; Jumadilova, Z; Nitz, NM | 1 |
| Girase, P; Jumadilova, Z; Ollendorf, DA; Varadharajan, S | 2 |
| Jumadilova, Z; Perfetto, EM; Subedi, P | 1 |
| Angelico, P; Guarneri, L; Leonardi, A; Sironi, G; Testa, R; Velasco, C | 1 |
| Appell, RA; Davila, GW; Dmochowski, RR; Nitti, VW; Sanders, SW | 1 |
| Caro, I; Caro, JJ; El-Hadi, W; Getsios, D | 1 |
| Kwong, YY; Lam, DS; Leung, DY | 1 |
| Sussman, DO; Taylor, PH | 1 |
| Maruyama, S; Oki, T; Takagi, Y; Yamada, S; Yamamura, HI | 1 |
| Dmochowski, RR | 1 |
| Agarwal, A; Dhiraaj, S; Kapoor, R; Singhal, V; Tandon, M | 1 |
| Kripke, C | 1 |
| MacDiarmid, SA; Staskin, DR | 1 |
| Appell, RA; McCrery, RJ; Smith, PP | 1 |
| Balaxis, E; Kalaitzis, C; Rombis, V; Touloupidis, S; Triantafyllidis, A | 1 |
| Arya, M; John, J; Khan, MS; Patel, HR; Sahai, A; Singh, R | 1 |
| Akgoz, S; Balkan, E; Dogruyol, H; Kilic, N; Sen, N | 1 |
| Anderson, RU; Barada, JH; Goldberg, RP; Kell, S; MacDiarmid, S; Serels, S | 1 |
| Ayers, A; O'Sullivan, DM; Tulikangas, PK | 1 |
| Brubaker, L; Chapple, C; Coyne, KS; Kopp, Z | 1 |
| Hegde, SS; Michel, MC | 1 |
| Leung, AK; Robson, WL | 1 |
| Hatanaka, T; Miyata, K; Noguchi, Y; Ohtake, A; Okutsu, H; Saitoh, C; Sasamata, M; Sato, S; Suzuki, M; Ukai, M; Yuyama, H | 1 |
| Kageyama, A; Oki, T; Takagi, Y; Uchida, S; Yamada, S | 1 |
| MacDiarmid, S; Rogers, A | 1 |
| Armstrong, RB; Dmochowski, RR; Macdiarmid, S; Sand, PK | 1 |
| Bertozzi, R; Cipriani, S; Colli, E; Meschia, M; Montorsi, F; Olivieri, L; Parazzini, F | 1 |
| Chancellor, MB; de Miguel, F | 1 |
| Newman, DK; Page, SA; Rosenberg, MT; Tallman, CT | 1 |
| Bolge, SC; Chen, A; McDonnell, DD; Wan, GJ | 1 |
| Chugh, A; Gupta, JB; Hegde, LG; Kumar, N; Meru, AV; Naruganahalli, KS; Ray, A; Sinha, S | 1 |
| Giramonti, KM; Halpern, LF; Kogan, BA | 1 |
| Jawade, KK; Taneja, R | 1 |
| Davila, GW | 1 |
| Hilas, O; Lam, S | 1 |
| Hasuike, N; Maruyama, S; Suzuki, K; Yamada, S | 1 |
| Amend, B; Hennenlotter, J; Horstmann, M; Schäfer, T; Sievert, KD; Stenzl, A | 1 |
| Kane, RL; Shamliyan, TA; Wilt, TJ; Wyman, J | 1 |
| Craig, B; Kritchevsky, S; Sands, LP; Sink, KM; Thomas, J; Xu, H | 1 |
| Ariely, R; D'Souza, AO; Doyle, J; Miller, LA; Smith, MJ | 1 |
| Artibani, W; Cavalleri, S; D'Elia, C; Ficarra, V; Galfano, A; Novara, G; Secco, S | 1 |
| MacDiarmid, S; Malhotra, BK; Sandage, BW | 1 |
| Yoshinaga, Y | 1 |
| Chatterjee, M; Chugh, A; Dastidar, S; Gupta, D; Gupta, S; Nanda, K; Ray, A; Singh, RK; Sundaram, S; Tiwari, A | 1 |
| Yang, SS | 1 |
| Jorgensen, TM | 1 |
| de Jong, TP | 1 |
| Bolduc, S; Hamel, M; Lamontagne, P; Lebel, S; Moore, K | 1 |
| Cardozo, L; Sidhu, M; Thorpe, A; Warner, J | 1 |
| Wyndaele, JJ | 1 |
| Fujino, T; Kageyama, A; Nozawa, Y; Yamada, S; Yoshida, A | 1 |
| Günendi, Z; Karataş, GK | 1 |
| Chen, CJ; Deng, YJ; Ge, Z; Guo, YF; Lu, RG; Ma, G; Wang, LX; Zhu, HB | 1 |
| Jakobsen, SM; Kersten, H; Molden, E | 1 |
| Bungay, PJ; Callegari, E; Fenner, KS; Kay, GG; Kempshall, S; LaPerle, JL; Malhotra, B; Michel, MC; Webster, R | 1 |
| Alves, SE; Donnelly, MJ; Gichuru, L; Hickey, EJ; Johnson, CV; Kulick, AA; Nagabukuro, H; Nichols, A; O'Neill, GP; Pereira, T; Tong, X; Villa, KL; Voronin, GO; Wickham, LA | 1 |
| Schröder, A; Thüroff, JW | 1 |
| Gomes, T; Juurlink, DN; Mamdani, MM | 1 |
| Gomes, T; Ho, JM; Juurlink, DN; Mamdani, MM; Schneeweiss, S | 1 |
| Chess-Williams, R; Moro, C; Uchiyama, J | 1 |
| Cody, JD; Ellis, G; Hay-Smith, EJ; Herbison, GP; Madhuvrata, P | 1 |
| Chapple, CR; Osman, NI | 1 |
| Kane, RL; Ramakrishnan, R; Sainfort, F; Shamliyan, T; Wyman, JF | 1 |
| Alessandri, F; Candiani, M; Ferrero, S; Leone Roberti Maggiore, U; Origoni, M; Remorgida, V; Salvatore, S; Venturini, PL | 1 |
| Chiang, CH; Chin, HY; Lin, KC; Wang, CJ | 1 |
| Dede, FS; Dede, H; Dolen, İ; Sivaslioglu, AA | 1 |
| Hatanaka, T; Kaku, S; Ohtake, A; Sato, S; Someya, A; Suzuki, M; Ueshima, K; Ukai, M; Watanabe, M | 1 |
| Abrams, P; Hart, WM; Munro, V; Nazir, J; Retsa, P | 1 |
| Fukata, A; Yamazaki, T | 1 |
| Akino, H; Fujiuchi, Y; Fuse, H; Kitagawa, Y; Miyazawa, K; Namiki, M; Suzuki, K; Yokoyama, O | 1 |
| Burckart, GJ; Green, DJ; Hirsch, M; Karesh, A; Khurana, M; Kim, MJ; Lee, J; Momper, JD; Mulugeta, Y; Sachs, HC; Yao, L | 1 |
| Kosilov, KV; Kosilova, LV; Krasnykh, MA; Loparev, SA | 1 |
| Blak, B; Hakimi, Z; Johnson, M; Nazir, J; Odeyemi, IA | 1 |
| Haghollahi, F; Jafarabadi, L; Jafarabadi, M; Rabie Salehi, G; Rashidi, BH; Shariat, M | 1 |
| Ariogul, S; Cankurtaran, E; Cankurtaran, M; Ergen, A; Esin, E; Halil, M; Kuyumcu, ME; Ozcan, M; Ulger, Z; Yavuz, BB; Yeşil, Y | 1 |
| Azimi Nekoo, E; Ghanbari, Z; Haghollahi, F; Hashemi, S; Jafarabadi, M; Nemati, M | 1 |
| Barkin, J; Berner, T; Diles, D; Franks, B | 1 |
| Hsiao, SM; Kuo, HC; Lin, HH | 1 |
| Deliktas, H; Gedik, A; Nergis, Y; Orgen, S; Sahin, H | 1 |
| Dandolu, V; Lua, LL; Pathak, P | 1 |
| Aballéa, S; Hakimi, Z; Kelleher, C; Maman, K; Mankowski, C; Nazir, J; Odeyemi, I | 1 |
| Herbison, P; McKenzie, JE | 1 |
| Cetinel, B; Dincer, M; Gultekin, MH; Guzelsoy, M; Onal, B; Turegun, FA | 1 |
| Almeida, FG; Bernardo, WM; Sacomani, CAR; Silvinato, A | 1 |
| Hansson, F; Kilany, S; Milsom, I; Schiotz, HA; Svensson, M | 1 |
| Ketai, LH; Komesu, YM; Mayer, AR; Rogers, RG; Sapien, RE; Schrader, RM | 1 |
| Rahardjo, HE; Rangganata, E; Widia, F | 1 |
| Panicker, JN; Richardson, K; Welk, B | 1 |
| Gomes, T; Herschorn, S; Jarvi, K; Juurlink, D; Matta, R; Nam, RK | 1 |
| Jaguaribe de Lima, AM; Lemos, A; Marcolino, MAZ; Moretti, E | 1 |
| Hiren Prajapati, HP; Krunal Vishavadia, KV; Madhu Sharma, MS; Sandip Solanki, SS | 1 |
| Chen, Y; Fang, L; Li, C; Liu, C; Liu, J; Mu, L; Sun, L; Wang, Z; Xi, H | 1 |
| Chakravarthi, S; Chellian, J; David, SR; Mun, CY; Rajabalaya, R | 1 |
| Kim, IS; Kim, TK; Seok Ji, Y; Yoo, HH | 1 |
57 review(s) available for oxybutynin and tolterodine tartrate
| Article | Year |
|---|---|
Tolterodine.
Topics: Animals; Benzhydryl Compounds; Cholinergic Antagonists; Controlled Clinical Trials as Topic; Cresols; Half-Life; Humans; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 1998 |
Tolterodine, a new antimuscarinic drug for treatment of bladder overactivity.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Drug Evaluation; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Urination Disorders | 1999 |
Muscarinic receptor antagonists in the treatment of overactive bladder.
Topics: Benzhydryl Compounds; Benzofurans; Clinical Trials as Topic; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2000 |
A pharmacoeconomic evaluation of two new products for the treatment of overactive bladder.
Topics: Benzhydryl Compounds; Budgets; Cholinergic Antagonists; Cost of Illness; Cost-Benefit Analysis; Cresols; Drug Costs; Humans; Mandelic Acids; Patient Compliance; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2000 |
Advancements in pharmacologic management of the overactive bladder.
Topics: Adrenergic alpha-Antagonists; Aged; Animals; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Benzilates; Benzofurans; Calcium Channel Blockers; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Drug Administration Routes; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Muscle Relaxants, Central; Nortropanes; Phenylpropanolamine; Pyrrolidines; Tolterodine Tartrate; Urinary Incontinence | 2000 |
Overactive bladder: optimizing quality of care.
Topics: Aged; Algorithms; Behavior Therapy; Benzhydryl Compounds; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Quality Assurance, Health Care; Tolterodine Tartrate; United States; Urinary Incontinence | 2001 |
Clinical experiences with tolterodine.
Topics: Animals; Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases | 2001 |
Tolterodine versus oxybutynin in the treatment of urge urinary incontinence: a meta-analysis.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2001 |
Tolterodine: a clinical review.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2001 |
Is tolterodine (Detrol) or oxybutynin (Ditropan) the best for treatment of urge urinary incontinence?
Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Confidence Intervals; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Evidence-Based Medicine; Female; Humans; Male; Mandelic Acids; Middle Aged; Phenylpropanolamine; Randomized Controlled Trials as Topic; Reference Values; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence, Stress | 2001 |
Pharmacotherapy of the overactive bladder and advances in drug delivery.
Topics: Administration, Intravesical; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Botulinum Toxins; Capsaicin; Cholinergic Antagonists; Cresols; Cystitis, Interstitial; Diterpenes; Humans; Mandelic Acids; Neurotoxins; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases; Urination Disorders | 2002 |
Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review.
Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence | 2002 |
Current pharmacotherapeutic strategies for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Incontinence; Urination Disorders | 2002 |
Pharmacologic treatment for detrusor overactivity.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders | 2002 |
The newer antimuscarinic drugs: bladder control with less dry mouth.
Topics: Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2002 |
The overactive bladder: a nursing perspective.
Topics: Activities of Daily Living; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cost of Illness; Cresols; Female; Humans; Imipramine; Information Services; Male; Mandelic Acids; Mass Screening; Medical History Taking; Muscarinic Antagonists; Nurse's Role; Nursing Assessment; Patient Acceptance of Health Care; Patient Education as Topic; Phenylpropanolamine; Physical Examination; Prevalence; Quality of Life; Social Behavior; Tolterodine Tartrate; Urination Disorders | 2002 |
Conservative management in neurogenic bladder dysfunction.
Topics: Anti-Dyskinesia Agents; Benzhydryl Compounds; Biofeedback, Psychology; Botulinum Toxins; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Diterpenes; Electric Stimulation Therapy; Humans; Infant; Infant, Newborn; Mandelic Acids; Meningomyelocele; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Catheterization | 2002 |
Achieving bladder control. Treatment in the primary care setting.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Estrogen Replacement Therapy; Female; Humans; Mandelic Acids; Medical History Taking; Middle Aged; Muscarinic Antagonists; Nurse Practitioners; Nursing Assessment; Phenylpropanolamine; Physical Examination; Primary Health Care; Referral and Consultation; Toilet Training; Tolterodine Tartrate; United States; Urinary Incontinence | 2002 |
Update on overactive bladder: pharmacologic approaches on the horizon.
Topics: Administration, Cutaneous; Administration, Intravesical; Administration, Oral; Adrenergic beta-3 Receptor Antagonists; Benzhydryl Compounds; Benzilates; Benzofurans; Botulinum Toxins; Cresols; Dosage Forms; Dose-Response Relationship, Drug; Drug Compounding; Drug Evaluation; Duloxetine Hydrochloride; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Thiophenes; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders | 2003 |
Overactive bladder: improving the efficacy of anticholinergics by dose escalation.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urination Disorders | 2003 |
Overactive bladder. Strategies for better recognition and management.
Topics: Behavior Therapy; Benzhydryl Compounds; Biofeedback, Psychology; Cresols; Diagnosis, Differential; Electric Stimulation Therapy; Exercise Therapy; Humans; Incidence; Mandelic Acids; Medical History Taking; Muscarinic Antagonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Pelvic Floor; Phenylpropanolamine; Physical Examination; Prevalence; Primary Health Care; Referral and Consultation; Toilet Training; Tolterodine Tartrate; United States; Urination Disorders; Urodynamics | 2004 |
Trospium chloride in the management of overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Biological Availability; Cresols; Female; Half-Life; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Randomized Controlled Trials as Topic; Receptors, Muscarinic; Tissue Distribution; Tolterodine Tartrate; Urinary Incontinence | 2004 |
Elevating our therapeutic expectations in overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2004 |
Overactive bladder: evaluation and management in primary care.
Topics: Algorithms; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Imipramine; Mandelic Acids; Phenylpropanolamine; Primary Health Care; Tolterodine Tartrate; Urinary Incontinence; Urinary Incontinence, Stress | 2005 |
Trospium chloride for the treatment of overactive bladder with urge incontinence.
Topics: Aging; Area Under Curve; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Female; Humans; Liver Failure; Male; Mandelic Acids; Metabolic Clearance Rate; Nortropanes; Phenylpropanolamine; Randomized Controlled Trials as Topic; Renal Insufficiency; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Assessment and management of urinary incontinence.
Topics: Aged; Behavior Therapy; Benzhydryl Compounds; Cresols; Exercise Therapy; Female; Humans; Male; Mandelic Acids; Mass Screening; Medical History Taking; Middle Aged; Muscarinic Antagonists; Nurse Practitioners; Nurse's Role; Nursing Assessment; Pelvic Floor; Phenylpropanolamine; Physical Examination; Prevalence; Risk Factors; Tolterodine Tartrate; United States; Urinalysis; Urinary Incontinence; Urodynamics | 2005 |
Which anticholinergic drug for overactive bladder symptoms in adults.
Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Pharmacological management of overactive bladder : a systematic and critical review of published economic evaluations.
Topics: Benzhydryl Compounds; Cost of Illness; Cresols; Female; Humans; Male; Mandelic Acids; Markov Chains; Middle Aged; Models, Economic; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
The puzzle of overactive bladder: controversies, inconsistencies, and insights.
Topics: Animals; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Parasympatholytics; Patient Compliance; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive | 2006 |
Anticholinergic drugs for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2006 |
Using anticholinergics to treat overactive bladder: the issue of treatment tolerability.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2006 |
The emergence of new drugs for overactive bladder.
Topics: Acetylcholine; Amines; Animals; Anticonvulsants; Benzhydryl Compounds; Cresols; Cyclohexanecarboxylic Acids; Drug Evaluation, Preclinical; Gabapentin; gamma-Aminobutyric Acid; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Product Surveillance, Postmarketing; Quinuclidines; Randomized Controlled Trials as Topic; Receptor, Muscarinic M3; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 2006 |
The overactive bladder: review of current pharmacotherapy in adults. Part 1: pathophysiology and anticholinergic therapy.
Topics: Administration, Cutaneous; Administration, Intravesical; Administration, Oral; Algorithms; Animals; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Models, Animal; Phenylpropanolamine; Practice Guidelines as Topic; Quality of Life; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence | 2006 |
A meta-analysis comparing trials of antimuscarinic medications funded by industry or not.
Topics: Benzhydryl Compounds; Cresols; Drug Industry; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Research Support as Topic; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2006 |
Patient-reported outcomes in overactive bladder: importance for determining clinical effectiveness of treatment.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Health Status; Humans; Mandelic Acids; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress | 2006 |
Treatment of the overactive bladder syndrome with muscarinic receptor antagonists: a matter of metabolites?
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2006 |
An approach to daytime wetting in children.
Topics: Arousal; Benzhydryl Compounds; Child; Child, Preschool; Constipation; Cresols; Diurnal Enuresis; Humans; Laughter; Mandelic Acids; Muscarinic Antagonists; Pelvic Floor; Phenylpropanolamine; Toilet Training; Tolterodine Tartrate; Ultrasonography; Urinary Bladder; Urinary Bladder, Neurogenic; Urinary Incontinence, Urge; Urodynamics; Vesico-Ureteral Reflux | 2006 |
Male overactive bladder: the role of urodynamics and anticholinergics.
Topics: Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Cystoscopy; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Multicenter Studies as Topic; Phenylpropanolamine; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Neck Obstruction; Urinary Bladder, Overactive; Urodynamics | 2007 |
Number of daytime micturitions and volume voided per micturition in the evaluation of efficacy of drugs for overactive bladder: findings from randomized clinical trials.
Topics: Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination | 2007 |
Treatment of overactive bladder: selective use of anticholinergic agents with low drug-drug interaction potential.
Topics: Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Overactive bladder: recognition requires vigilance for symptoms.
Topics: Benzhydryl Compounds; Cost of Illness; Cresols; Female; Humans; Male; Mandelic Acids; Mass Screening; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Update on drugs for overactive bladder syndrome.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Patient satisfaction with extended release tolterodine or oxybutynin in overactive bladder.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Compliance; Patient Satisfaction; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Bladder, Overactive | 2007 |
Transdermal oxybutynin in the treatment of overactive bladder.
Topics: Administration, Topical; Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Parasympatholytics; Patient Satisfaction; Phenylpropanolamine; Technology, Pharmaceutical; Tolterodine Tartrate; Urinary Bladder, Overactive | 2006 |
Pharmacologic management of overactive bladder.
Topics: Benzhydryl Compounds; Benzofurans; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2007 |
Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Collagen; Cresols; Duloxetine Hydrochloride; Electric Stimulation Therapy; Estrogen Replacement Therapy; Exercise Therapy; Female; Humans; Magnetics; Mandelic Acids; Pelvic Floor; Pessaries; Phenylpropanolamine; Randomized Controlled Trials as Topic; Thiophenes; Tolterodine Tartrate; Urinary Incontinence | 2008 |
A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder.
Topics: Benzhydryl Compounds; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Overactive | 2008 |
[Multinational clinical trial in Japan and Korea on detrusitol].
Topics: Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; International Cooperation; Japan; Korea; Male; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder, Overactive | 2009 |
New strategies for medical management of overactive bladder in children.
Topics: Benzhydryl Compounds; Benzilates; Botulinum Toxins; Child; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination | 2010 |
Which anticholinergic drug for overactive bladder symptoms in adults.
Topics: Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
Benefits and harms of pharmacologic treatment for urinary incontinence in women: a systematic review.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Comparative Effectiveness Research; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Quinuclidines; Randomized Controlled Trials as Topic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Incontinence | 2012 |
Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Chronic Disease; Cresols; Drug Combinations; Female; Humans; Imidazoles; Mandelic Acids; Muscarinic Antagonists; Nocturia; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Incontinence | 2012 |
Comparative efficacy and tolerability of solifenacin 5 mg/day versus other oral antimuscarinic agents in overactive bladder: A systematic literature review and network meta-analysis.
Topics: Benzhydryl Compounds; Benzilates; Humans; Mandelic Acids; Muscarinic Antagonists; Network Meta-Analysis; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2018 |
Which anticholinergic is best for people with overactive bladders? A network meta-analysis.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Cholinergic Antagonists; Humans; Imidazoles; Mandelic Acids; Network Meta-Analysis; Pyrrolidines; Solifenacin Succinate; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2019 |
Effect of Antimuscarinic Drugs on Cognitive Functions in the Management of Overactive Bladder in Elderly.
Topics: Aged; Benzofurans; Cognition Disorders; Humans; Mandelic Acids; Mental Status and Dementia Tests; Muscarinic Antagonists; Pyrrolidines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2020 |
The cognitive effect of anticholinergics for patients with overactive bladder.
Topics: Benzhydryl Compounds; Benzofurans; Cholinergic Antagonists; Cognition; Cognitive Dysfunction; Dementia; Humans; Mandelic Acids; Prodromal Symptoms; Pyrrolidines; Risk Assessment; Risk Factors; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive | 2021 |
Eficácia E Custo-Utilidade De Intervenções Para O Tratamento Da Enurese Em Crianças E Adolescentes Sob A Perspectiva Do Sistema Único De Saúde Brasileiro: Effectiveness and Cost-Utility of Interventions for Enuresis Treatment in Children and Adolescents F
Topics: Adolescent; Brazil; Child; Deamino Arginine Vasopressin; Enuresis; Humans; Tolterodine Tartrate | 2023 |
39 trial(s) available for oxybutynin and tolterodine tartrate
| Article | Year |
|---|---|
Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis.
Topics: Adult; Analysis of Variance; Benzhydryl Compounds; Chi-Square Distribution; Cholinergic Antagonists; Confidence Intervals; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Statistics, Nonparametric; Time Factors; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination | 1997 |
Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder.
Topics: Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urination; Urination Disorders | 1998 |
Clinical efficacy and safety of tolterodine compared to oxybutynin and placebo in patients with overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence; Urination | 1999 |
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nervous System Diseases; Phenylpropanolamine; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress; Urination Disorders; Xerostomia | 2001 |
Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urination | 2001 |
A comparison of the effects on saliva output of oxybutynin chloride and tolterodine tartrate.
Topics: Adult; Area Under Curve; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Cross-Over Studies; Double-Blind Method; Female; Headache; Humans; Male; Mandelic Acids; Phenylpropanolamine; Saliva; Salivation; Tartrates; Tolterodine Tartrate | 2001 |
Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system.
Topics: Adult; Benzhydryl Compounds; Benzilates; Central Nervous System; Cresols; Electroencephalography; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Placebos; Tolterodine Tartrate | 2001 |
Tolterodine: selectivity for the urinary bladder over the eye (as measured by visual accommodation) in healthy volunteers.
Topics: Adult; Benzhydryl Compounds; Cresols; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Eye; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder | 2002 |
Tolterodine: as effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder.
Topics: Adult; Aged; Aged, 80 and over; Asian People; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urination | 2002 |
A randomized controlled trial of tolterodine and oxybutynin on tolerability and clinical efficacy for treating Chinese women with an overactive bladder.
Topics: Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Agonists; Patient Compliance; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2002 |
Treatment of overactive bladder with once-daily extended-release tolterodine or oxybutynin: the antimuscarinic clinical effectiveness trial (ACET).
Topics: Adult; Aged; Analysis of Variance; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urination | 2002 |
Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Dosage Forms; Female; Humans; Male; Mandelic Acids; Phenylpropanolamine; Retrospective Studies; Tartrates; Tolterodine Tartrate; Urinary Incontinence | 2003 |
Comparative efficacy and safety of transdermal oxybutynin and oral tolterodine versus placebo in previously treated patients with urge and mixed urinary incontinence.
Topics: Administration, Cutaneous; Administration, Oral; Benzhydryl Compounds; Cresols; Dermatitis, Contact; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence, Stress | 2003 |
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial.
Topics: Administration, Oral; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Diarrhea; Double-Blind Method; Female; Headache; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Salivation; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Tract Infections; Urination | 2003 |
Transdermal oxybutynin: for overactive bladder.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Exanthema; Humans; Mandelic Acids; Middle Aged; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia | 2003 |
Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder Diseases; Urinary Incontinence; Urination | 2003 |
Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Health Status Indicators; Humans; Japan; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Urinary Incontinence | 2004 |
Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.
Topics: Adult; Benzhydryl Compounds; Cresols; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Multiple Sclerosis; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Spinal Cord Injuries; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Xerostomia | 2004 |
Effect of antacid on the pharmacokinetics of extended-release formulations of tolterodine and oxybutynin.
Topics: Adolescent; Adult; Antacids; Benzhydryl Compounds; Cresols; Cross-Over Studies; Delayed-Action Preparations; Female; Humans; Hydrogen-Ion Concentration; Male; Mandelic Acids; Middle Aged; Phenylpropanolamine; Tolterodine Tartrate | 2004 |
Comparison of the efficacy of tolterodine and oxybutynin in different urodynamic severity grades of idiopathic detrusor overactivity.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Cross-Over Studies; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Severity of Illness Index; Tolterodine Tartrate; Urinary Incontinence; Urodynamics | 2004 |
Effects on sleep of anticholinergics used for overactive bladder treatment in healthy volunteers aged > or = 50 years.
Topics: Aged; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cognition; Cresols; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Polysomnography; Sleep, REM; Tolterodine Tartrate | 2005 |
Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial.
Topics: Accommodation, Ocular; Adult; Benzhydryl Compounds; Cresols; Eye Diseases; Humans; Intraocular Pressure; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Pupil; Single-Blind Method; Tears; Tolterodine Tartrate; Urinary Incontinence; Visual Acuity | 2005 |
Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Area Under Curve; Benzhydryl Compounds; Cresols; Cross-Over Studies; Delayed-Action Preparations; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Omeprazole; Phenylpropanolamine; Tolterodine Tartrate | 2005 |
Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Severity of Illness Index; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2005 |
Comparison of efficacy of oxybutynin and tolterodine for prevention of catheter related bladder discomfort: a prospective, randomized, placebo-controlled, double-blind study.
Topics: Adult; Anti-Infective Agents, Urinary; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Intraoperative Care; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nephrostomy, Percutaneous; Phenylpropanolamine; Postoperative Complications; Prospective Studies; Severity of Illness Index; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Catheterization; Urinary Incontinence | 2006 |
Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability.
Topics: Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Incontinence | 2006 |
Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Demography; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Dropouts; Patient Participation; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge | 2006 |
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2007 |
The effects of anticholinergic drugs on attention span and short-term memory skills in children.
Topics: Attention; Benzhydryl Compounds; Child; Child Behavior; Cholinergic Antagonists; Cognition; Cresols; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Memory; Mental Recall; Neuropsychological Tests; Phenylpropanolamine; Prospective Studies; Time Factors; Tolterodine Tartrate; Urinary Incontinence, Urge | 2008 |
A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis.
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Anticoagulants; Benzhydryl Compounds; Cresols; Cystitis, Interstitial; Drug Therapy, Combination; Female; Heparin; Humans; Hydrocortisone; Injections, Intramuscular; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Triamcinolone | 2007 |
Effective treatment of neurogenic detrusor dysfunction by combined high-dosed antimuscarinics without increased side-effects.
Topics: Adolescent; Adult; Benzhydryl Compounds; Benzilates; Cresols; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Spinal Cord Diseases; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urodynamics | 2008 |
Double anticholinergic therapy for refractory overactive bladder.
Topics: Adolescent; Algorithms; Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Urinary Bladder, Overactive | 2009 |
[Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder].
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2011 |
What is the success of drug treatment in urge urinary incontinence? What should be measured?
Topics: Adult; Benzhydryl Compounds; Benzilates; Cresols; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2013 |
[Treatment of overactive bladder in older women increased doses of antimuscarinic drugs safe and effective alternative to existing methods].
Topics: Aged; Benzhydryl Compounds; Benzilates; Cresols; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urodynamics | 2014 |
Considering the prominent complaint as a guide in medical therapy for overactive bladder syndrome in women over 45 years.
Topics: Aged; Double-Blind Method; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Tolterodine Tartrate; Urinary Bladder, Overactive | 2015 |
Prominent complaint: a guide to medical therapy of overactive bladder syndrome in older women.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Iran; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Syndrome; Tolterodine Tartrate; Urinary Bladder, Overactive | 2015 |
Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial.
Topics: Adult; Aged; Benzhydryl Compounds; Benzilates; Benzofurans; Blood Pressure; Female; Heart Rate; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nortropanes; Prospective Studies; Pyrrolidines; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
Hypnotherapy or medications: a randomized noninferiority trial in urgency urinary incontinent women.
Topics: Adult; Aged; Female; Humans; Hypnosis; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Single-Blind Method; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence, Urge | 2020 |
90 other study(ies) available for oxybutynin and tolterodine tartrate
| Article | Year |
|---|---|
Tolterodine--a new bladder-selective antimuscarinic agent.
Topics: Adult; Aged; Analgesia; Animals; Atropine; Benzhydryl Compounds; Cats; CHO Cells; Cholinergic Antagonists; Cresols; Cricetinae; Dose-Response Relationship, Drug; Female; Guinea Pigs; Humans; Infusions, Intravenous; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Muscle Contraction; Phenylpropanolamine; Salivation; Tolterodine Tartrate; Urinary Bladder | 1997 |
Pharmacological effects of tolterodine on human isolated urinary bladder.
Topics: Aged; Benzhydryl Compounds; Benzilates; Calcium Chloride; Carbachol; Cresols; Dose-Response Relationship, Drug; Electric Stimulation; Female; Humans; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Parasympatholytics; Phenylpropanolamine; Potassium Chloride; Tolterodine Tartrate; Urinary Bladder | 1999 |
Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Cresols; Drug Prescriptions; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Parasympatholytics; Pharmaceutical Services; Phenylpropanolamine; Retrospective Studies; Time Factors; Tolterodine Tartrate; Urinary Incontinence | 2000 |
Effects of TAK-637, a tachykinin receptor antagonist, on the micturition reflex in guinea pigs.
Topics: Animals; Benzhydryl Compounds; Benzilates; Capsaicin; Cholinergic Antagonists; Cresols; Dilatation; Dose-Response Relationship, Drug; Guinea Pigs; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle Relaxants, Central; Naphthyridines; Parasympatholytics; Phenylpropanolamine; Piperidines; Propiophenones; Receptors, Tachykinin; Reflex; Tolterodine Tartrate; Urinary Bladder; Urination | 2000 |
Possible site of action of TAK-637, a tachykinin NK(1) receptor antagonist, on the micturition reflex in guinea pigs.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Carbachol; Cresols; Denervation; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Humans; In Vitro Techniques; Male; Mandelic Acids; Muscle Contraction; Naphthyridines; Pelvis; Phenylpropanolamine; Reflex; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Diseases | 2000 |
Functional characterization of rat submaxillary gland muscarinic receptors using microphysiometry.
Topics: Alkaloids; Animals; Atropine; Benzhydryl Compounds; Benzodiazepinones; Binding, Competitive; Biosensing Techniques; Carbachol; Cholinergic Agonists; Cresols; Diamines; Dose-Response Relationship, Drug; Furans; Male; Mandelic Acids; Muscarinic Antagonists; Naphthalenes; Phenethylamines; Phenylpropanolamine; Piperidines; Pirenzepine; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Submandibular Gland; Tolterodine Tartrate | 2001 |
Detrol LA and Diropan XL for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Female; Headache; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders; Xerostomia | 2001 |
Clarification--Drug risk in patients with glaucoma.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Contraindications; Cresols; Glaucoma, Angle-Closure; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate | 2001 |
Is extended-release oxybutynin (Ditropan XL) or tolterodine (Detrol) more effective in the treatment of an overactive bladder?
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Phenylpropanolamine; Prospective Studies; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2001 |
Modern pharmacotherapy of urge urinary incontinence in the USA: tolterodine and oxybutynin.
Topics: Aged; Behavior Therapy; Benzhydryl Compounds; Combined Modality Therapy; Cresols; Female; Humans; Male; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Muscle Contraction; Parasympatholytics; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; United States; Urinary Incontinence | 2000 |
Costs and resources associated with the treatment of overactive bladder using retrospective medical care claims data.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Comorbidity; Cost of Illness; Cresols; Female; Health Care Costs; Humans; Insurance Claim Reporting; Longitudinal Studies; Male; Managed Care Programs; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Retrospective Studies; Tolterodine Tartrate; United States; Urinary Incontinence | 2001 |
POEMS (patient-oriented evidence that matters) spark discussion.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Evidence-Based Medicine; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2001 |
Medical treatment of overactive bladder.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Statistics as Topic; Tolterodine Tartrate; Urinary Incontinence | 2001 |
Cost-Effectiveness of tolterodine for patients with urge incontinence who discontinue initial therapy with oxybutynin: a Canadian perspective.
Topics: Benzhydryl Compounds; Canada; Cost-Benefit Analysis; Cresols; Economics, Pharmaceutical; Humans; Mandelic Acids; Markov Chains; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Severity of Illness Index; Tolterodine Tartrate; Urinary Incontinence | 2001 |
Medication update.
Topics: Adrenergic alpha-Antagonists; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Deamino Arginine Vasopressin; Humans; Imipramine; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Renal Agents; Tolterodine Tartrate; Urinary Incontinence | 2002 |
Assessment and conservative management of the neuropathic bladder.
Topics: Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Female; Humans; Infant; Male; Mandelic Acids; Meningomyelocele; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Catheterization | 2002 |
Treatment can lead to a long dry spell.
Topics: Behavior Therapy; Benzhydryl Compounds; Cresols; Female; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Parasympatholytics; Phenylpropanolamine; Physical Therapy Modalities; Tolterodine Tartrate; United States; Urinary Incontinence | 2002 |
Treatments for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Female; Humans; Male; Mandelic Acids; Phenylpropanolamine; Tartrates; Tolterodine Tartrate; Urinary Incontinence | 2000 |
New treatment options for overactive bladder and incontinence.
Topics: Aged; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Geriatric Assessment; Geriatric Nursing; Humans; Mandelic Acids; Muscarinic Antagonists; Nurse's Role; Nursing Assessment; Nursing Homes; Phenylpropanolamine; Prevalence; Toilet Training; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2002 |
Treatment of overactive bladder: the Antimuscarinic Clinical Effectiveness Trial.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders | 2002 |
Different responses to drugs against overactive bladder in detrusor muscle of pig, guinea pig and mouse.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Carbachol; Cholinergic Agonists; Cholinergic Antagonists; Cresols; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; In Vitro Techniques; Male; Mandelic Acids; Mice; Mice, Inbred C57BL; Muscle Contraction; Muscle, Smooth; Phenylpropanolamine; Species Specificity; Swine; Tolterodine Tartrate; Urinary Bladder | 2002 |
Methodologic shortcomings inherent in a post-hoc analysis.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Humans; Mandelic Acids; Phenylpropanolamine; Tartrates; Tolterodine Tartrate; Urinary Bladder Diseases | 2002 |
The use of tolterodine in children after oxybutynin failure.
Topics: Adolescent; Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Cresols; Cross-Over Studies; Enuresis; Female; Humans; Infant; Male; Mandelic Acids; Phenylpropanolamine; Prospective Studies; Tartrates; Tolterodine Tartrate; Treatment Failure; Urinary Incontinence | 2003 |
[Urinary incontinence--treatment].
Topics: Adrenergic Uptake Inhibitors; Behavior Therapy; Benzhydryl Compounds; Benzilates; Biofeedback, Psychology; Cholinergic Antagonists; Contraindications; Cresols; Deamino Arginine Vasopressin; Electric Stimulation Therapy; Female; Humans; Imipramine; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Parasympatholytics; Phenylpropanolamine; Physical Therapy Modalities; Renal Agents; Tolterodine Tartrate; Urinary Incontinence; Urinary Incontinence, Stress | 2003 |
Oxybutynin transdermal (Oxytrol) for overactive bladder.
Topics: Administration, Cutaneous; Administration, Oral; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Xerostomia | 2003 |
RE: Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence.
Topics: Benzhydryl Compounds; Child; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Dosage Forms; Humans; Mandelic Acids; Phenylpropanolamine; Research Design; Retrospective Studies; Tartrates; Tolterodine Tartrate; Urinary Incontinence | 2003 |
Advances in medical management of overactive bladder.
Topics: Administration, Cutaneous; Administration, Oral; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Salivation; Tolterodine Tartrate; Treatment Outcome; United States; Urinary Incontinence; Urination | 2003 |
Comparison of in vitro selectivity profiles of solifenacin succinate (YM905) and current antimuscarinic drugs in bladder and salivary glands: a Ca2+ mobilization study in monkey cells.
Topics: Animals; Benzhydryl Compounds; Benzofurans; Calcium; Calcium Signaling; Carbachol; Cresols; Dose-Response Relationship, Drug; In Vitro Techniques; Inhibitory Concentration 50; Macaca fascicularis; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Submandibular Gland; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder | 2004 |
Canadian economic comparison of extended-release oxybutynin and immediate-release tolterodine in the treatment of overactive bladder.
Topics: Benzhydryl Compounds; Canada; Costs and Cost Analysis; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Markov Chains; Middle Aged; Models, Economic; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases | 2004 |
Use of the short form of King's Health Questionnaire to measure quality of life in patients with an overactive bladder.
Topics: Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Multicenter Studies as Topic; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Randomized Controlled Trials as Topic; Reproducibility of Results; Surveys and Questionnaires; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence | 2004 |
In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzofurans; Calcium; Cresols; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Myocytes, Smooth Muscle; Organ Specificity; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Wistar; Solifenacin Succinate; Submandibular Gland; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder | 2004 |
Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cost-Benefit Analysis; Cresols; Delayed-Action Preparations; Drug Costs; Female; Humans; Male; Mandelic Acids; Middle Aged; Models, Economic; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2004 |
[Therapy of bladder weakness].
Topics: Adult; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder-afferent pathways.
Topics: Acetylcholine; Administration, Intravesical; Afferent Pathways; Animals; Atropine; Benzhydryl Compounds; Benzilates; Carbachol; Cresols; Dimethindene; Female; Infusions, Parenteral; Instillation, Drug; Mandelic Acids; Muscarinic Agonists; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Nortropanes; Phenylpropanolamine; Pressure; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Tolterodine Tartrate; Urinary Bladder; Urodynamics | 2005 |
Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
Topics: Adolescent; Behavior Therapy; Benzhydryl Compounds; Child; Child, Preschool; Cholinergic Antagonists; Combined Modality Therapy; Cresols; Drug Evaluation; Drug Resistance; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Patient Compliance; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Design, synthesis and activity of novel derivatives of oxybutynin and tolterodine.
Topics: Animals; Benzhydryl Compounds; Binding Sites; Cresols; Drug Design; Mandelic Acids; Phenylpropanolamine; Rats; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Structure-Activity Relationship; Tolterodine Tartrate | 2005 |
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial.
Topics: Benzhydryl Compounds; Central Nervous System; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Persistence with overactive bladder pharmacotherapy in a Medicaid population.
Topics: Adolescent; Adult; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Male; Mandelic Acids; Medicaid; Middle Aged; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Medical costs after initiation of drug treatment for overactive bladder: effects of selection bias on cost estimates.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Female; Health Care Costs; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Selection Bias; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Economic impact of extended-release tolterodine versus immediate- and extended-release oxybutynin among commercially insured persons with overactive bladder.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Female; Humans; Insurance Coverage; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Treatment of overactive bladder: a model comparing extended-release formulations of tolterodine and oxybutynin.
Topics: Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Health Care Costs; Humans; Mandelic Acids; Models, Theoretical; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.
Topics: Animals; Benzhydryl Compounds; Cresols; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Rats; Tolterodine Tartrate; Urinary Bladder; Urinary Catheterization; Urinary Incontinence; Urination | 2005 |
Bladder-health diaries: an assessment of 3-day vs 7-day entries.
Topics: Benzhydryl Compounds; Chi-Square Distribution; Cresols; Humans; Mandelic Acids; Medical Records; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Time; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder; Urinary Incontinence | 2005 |
Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial.
Topics: Accommodation, Ocular; Benzhydryl Compounds; Cresols; Eye Diseases; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence | 2005 |
Contemporary treatment options for overactive bladder.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Exercise; Female; Humans; Life Style; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prevalence; Sex Factors; Tolterodine Tartrate; United States; Urinary Incontinence | 2005 |
Characterization of muscarinic receptor binding and inhibition of salivation after oral administration of tolterodine in mice.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Male; Mandelic Acids; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Myocardium; Phenylpropanolamine; Protein Binding; Receptors, Muscarinic; Salivation; Submandibular Gland; Tolterodine Tartrate; Urinary Bladder | 2006 |
Intravesical instillation of human urine after oral administration of trospium, tolterodine and oxybutynin in a rat model of detrusor overactivity.
Topics: Administration, Intravesical; Analysis of Variance; Animals; Benzhydryl Compounds; Cresols; Female; Humans; Mandelic Acids; Muscarinic Antagonists; Muscle, Smooth; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Tolterodine Tartrate; Urinary Bladder; Urinary Incontinence | 2006 |
Nocturnal enuresis in children. A four-year experience in outpatient clinics of pediatric urology.
Topics: Adolescent; Antidiuretic Agents; Behavior Therapy; Benzhydryl Compounds; Chi-Square Distribution; Child; Combined Modality Therapy; Cresols; Deamino Arginine Vasopressin; Drug Therapy, Combination; Enuresis; Female; Greece; Humans; Male; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome | 2005 |
Retrospective evaluation of outcomes in patients with overactive bladder receiving tolterodine versus oxybutynin.
Topics: Benzhydryl Compounds; Comorbidity; Cresols; Delayed-Action Preparations; Depression; Female; Fractures, Bone; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Retrospective Studies; Risk; Tolterodine Tartrate; United States; Urinary Bladder, Overactive; Urinary Tract Infections | 2006 |
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Benzofurans; Binding, Competitive; Carbachol; CHO Cells; Cholinergic Agonists; Cresols; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Muscarinic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Transfection; Urinary Bladder; Urinary Bladder, Overactive; Urination | 2007 |
Comparative evaluation of central muscarinic receptor binding activity by oxybutynin, tolterodine and darifenacin used to treat overactive bladder.
Topics: Animals; Benzhydryl Compounds; Benzofurans; Cerebral Cortex; Cresols; In Vitro Techniques; Male; Mandelic Acids; Mice; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Receptors, Muscarinic; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder, Overactive | 2007 |
Comparative in vivo uroselectivity profiles of anticholinergics, tested in a novel anesthetized rabbit model.
Topics: Anesthesia; Animals; Benzhydryl Compounds; Benzofurans; Carbachol; Cholinergic Antagonists; Cresols; Injections, Intra-Arterial; Male; Mandelic Acids; Phenylpropanolamine; Pressure; Pyrrolidines; Quinuclidines; Rabbits; Salivary Glands; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder | 2007 |
In vivo characterization of muscarinic receptors in peripheral tissues: evaluation of bladder selectivity of anticholinergic agents to treat overactive bladder.
Topics: Administration, Oral; Animals; Area Under Curve; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Male; Mandelic Acids; Mice; Muscarinic Antagonists; Phenylpropanolamine; Protein Binding; Quinuclidinyl Benzilate; Receptors, Muscarinic; Time Factors; Tolterodine Tartrate; Urinary Bladder, Overactive | 2008 |
Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Benzhydryl Compounds; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Cresols; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Homes for the Aged; Humans; Male; Mandelic Acids; Neuropsychological Tests; Nursing Homes; Phenylpropanolamine; Prospective Studies; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence | 2008 |
Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan.
Topics: Adult; Aged; Benzhydryl Compounds; Cohort Studies; Cresols; Databases, Factual; Delayed-Action Preparations; Female; Follow-Up Studies; Humans; Male; Managed Care Programs; Mandelic Acids; Middle Aged; Multivariate Analysis; Muscarinic Antagonists; Patient Compliance; Phenylpropanolamine; Retrospective Studies; Tolterodine Tartrate; Treatment Refusal; United States; Urinary Bladder, Overactive | 2008 |
The effects of reformulation: improved therapeutic index.
Topics: Benzhydryl Compounds; Benzilates; Chemistry, Pharmaceutical; Cresols; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2008 |
Ratiometric Ca+2 measurement in human recombinant muscarinic receptor subtypes using the Flexstation scanning fluorometer.
Topics: Animals; Atropine; Benzhydryl Compounds; Calcium; CHO Cells; Cresols; Cricetinae; Cricetulus; Fluorescence; Fluorescent Dyes; Fluorometry; Fura-2; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Radioligand Assay; Receptor, Muscarinic M1; Receptor, Muscarinic M3; Receptor, Muscarinic M5; Scopolamine Derivatives; Tolterodine Tartrate; Transfection | 2009 |
Editorial comment.
Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2009 |
Editorial comment.
Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2009 |
Editorial comment.
Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive | 2009 |
The cost-effectiveness of solifenacin vs fesoterodine, oxybutynin immediate-release, propiverine, tolterodine extended-release and tolterodine immediate-release in the treatment of patients with overactive bladder in the UK National Health Service.
Topics: Benzhydryl Compounds; Benzilates; Cost-Benefit Analysis; Cresols; Decision Trees; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2010 |
Pediatrics: combining antimuscarinics shows promise for overactive bladder.
Topics: Benzhydryl Compounds; Child; Cresols; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Pediatrics; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2010 |
Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis.
Topics: Adenosine Triphosphate; Animals; Benzhydryl Compounds; Benzofurans; Cresols; Cystitis; Disease Models, Animal; Down-Regulation; Female; Hydrochloric Acid; Mandelic Acids; N-Methylscopolamine; Organophosphonates; Phenols; Phenylpropanolamine; Pirenzepine; Polycyclic Compounds; Pyridoxal Phosphate; Pyrrolidines; Quinuclidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Receptors, Purinergic; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urination; Urodynamics | 2010 |
Do anticholinergics affect reaction time? A possible impact on the course of rehabilitation.
Topics: Administration, Oral; Adult; Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Cross-Over Studies; Electric Stimulation; Electromyography; Female; Hand; Humans; Male; Mandelic Acids; Middle Aged; Muscle, Skeletal; Neuropsychological Tests; Phenylpropanolamine; Reaction Time; Reference Values; Tolterodine Tartrate | 2010 |
Evaluation of brain anticholinergic activities of urinary spasmolytic drugs using a high-throughput radio receptor bioassay.
Topics: Benzhydryl Compounds; Benzofurans; Biological Assay; Brain; Cognition Disorders; Cresols; Humans; In Vitro Techniques; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate | 2011 |
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Benzhydryl Compounds; Benzofurans; Blood-Brain Barrier; Brain; Cell Line; Chromatography, High Pressure Liquid; Cresols; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Randomized Controlled Trials as Topic; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Solifenacin Succinate; Tandem Mass Spectrometry; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder, Overactive | 2011 |
Comparative analysis of the effects of antimuscarinic agents on bladder functions in both nonhuman primates and rodents.
Topics: Animals; Benzhydryl Compounds; Cresols; Female; Macaca mulatta; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Rats; Rats, Sprague-Dawley; Species Specificity; Tolterodine Tartrate; Urinary Bladder | 2011 |
Comparative adherence to oxybutynin or tolterodine among older patients.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Cresols; Databases, Factual; Drug Prescriptions; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Medication Adherence; Muscarinic Antagonists; National Health Programs; Ontario; Phenylpropanolamine; Proportional Hazards Models; Retrospective Studies; Tolterodine Tartrate; Urinary Incontinence, Urge | 2012 |
Risk of serious falls associated with oxybutynin and tolterodine: a population based study.
Topics: Accidental Falls; Aged; Benzhydryl Compounds; Cresols; Emergency Service, Hospital; Hospitalization; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Risk Factors; Tolterodine Tartrate; Urinary Incontinence, Urge | 2011 |
Urothelial/lamina propria spontaneous activity and the role of M3 muscarinic receptors in mediating rate responses to stretch and carbachol.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzofurans; Carbachol; Cresols; Diamines; Mandelic Acids; Mucous Membrane; Muscarinic Antagonists; Muscle Contraction; Phenylpropanolamine; Piperidines; Pirenzepine; Pyrrolidines; Quinuclidines; Receptor, Muscarinic M3; Solifenacin Succinate; Stress, Mechanical; Swine; Tetrahydroisoquinolines; Tolterodine Tartrate; Urinary Bladder; Urothelium | 2011 |
Lower urinary tract symptoms revisited.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Benzhydryl Compounds; Cresols; Cystitis, Interstitial; Doxazosin; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate | 2012 |
Combination of baclofen and antimuscarinics to reduce voiding difficulty in treating women with overactive bladders.
Topics: Adult; Aged; Baclofen; Benzhydryl Compounds; Community-Based Participatory Research; Cresols; Drug Therapy, Combination; Female; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder, Overactive; Urination; Urodynamics; Young Adult | 2012 |
Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Animals; Benzhydryl Compounds; Cresols; Dose-Response Relationship, Drug; Female; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Rats; Rats, Wistar; Thiazoles; Tolterodine Tartrate; Urinary Bladder; Urinary Bladder Neck Obstruction | 2013 |
Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom.
Topics: Benzhydryl Compounds; Cohort Studies; Cost-Benefit Analysis; Cresols; Humans; Incontinence Pads; Mandelic Acids; Markov Chains; Medication Adherence; Models, Economic; Muscarinic Antagonists; Patient Dropouts; Phenylpropanolamine; Quality-Adjusted Life Years; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; United Kingdom; Urinary Bladder, Overactive; Urinary Incontinence | 2013 |
Imidafenacin has no influence on learning in nucleus basalis of Meynert-lesioned rats.
Topics: Animals; Basal Nucleus of Meynert; Behavior, Animal; Benzhydryl Compounds; Blood-Brain Barrier; Capillary Permeability; Cresols; Dose-Response Relationship, Drug; Imidazoles; Injections, Intravenous; Injections, Intraventricular; Learning; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Rats; Rats, Wistar; Reaction Time; Tolterodine Tartrate | 2013 |
Factors influencing patient satisfaction with antimuscarinic treatment of overactive bladder syndrome: results of a real-life clinical study.
Topics: Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Cresols; Cross-Sectional Studies; Female; Humans; Imidazoles; Japan; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Patient Satisfaction; Phenylpropanolamine; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2014 |
Drug development for pediatric neurogenic bladder dysfunction: dosing, endpoints, and study design.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Area Under Curve; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Delayed-Action Preparations; Humans; Infant; Mandelic Acids; Marine Toxins; Muscarinic Antagonists; Oxocins; Phenylpropanolamine; Quinazolines; Tablets; Tolterodine Tartrate; Urinary Bladder, Neurogenic | 2014 |
Drug treatment patterns for the management of men with lower urinary tract symptoms associated with benign prostatic hyperplasia who have both storage and voiding symptoms: a study using the health improvement network UK primary care data.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Benzhydryl Compounds; Cresols; Family Practice; Humans; Lower Urinary Tract Symptoms; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Primary Health Care; Prostatic Hyperplasia; Quinuclidines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tetrahydroisoquinolines; Tolterodine Tartrate; United Kingdom | 2015 |
Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzilates; Benzofurans; Cognition Disorders; Cresols; Depression; Female; Follow-Up Studies; Geriatric Assessment; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive | 2015 |
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence.
Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate | 2015 |
Treatment Outcome of Overactive Bladder Patients Receiving Antimuscarinic Therapy for More than One Year.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Constipation; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Retrospective Studies; Severity of Illness Index; Solifenacin Succinate; Time Factors; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urodynamics; Vision Disorders; Xerostomia; Young Adult | 2018 |
Histopathologic and Urodynamic Effects of the Anticholinergic Drugs Oxybutynin, Tolterodine, and Trospium on the Bladder.
Topics: Animals; Benzilates; Male; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Rabbits; Random Allocation; Tolterodine Tartrate; Urinary Bladder; Urological Agents; Urothelium | 2017 |
Comparing anticholinergic persistence and adherence profiles in overactive bladder patients based on gender, obesity, and major anticholinergic agents.
Topics: Adolescent; Adult; Cholinergic Antagonists; Female; Humans; Male; Mandelic Acids; Medication Adherence; Middle Aged; Obesity; Quality of Life; Sex Factors; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive; Young Adult | 2017 |
Overactive bladder - pharmacological treatment.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Antidepressive Agents; Benzilates; Benzofurans; Brazil; Clinical Decision-Making; Drug Therapy, Combination; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Pyrrolidines; Solifenacin Succinate; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
A Nordic registry-based study of drug treatment patterns in overactive bladder patients.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzofurans; Denmark; Female; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Norway; Practice Patterns, Physicians'; Prospective Studies; Pyrrolidines; Registries; Solifenacin Succinate; Sweden; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive | 2019 |
Receipt of Overactive Bladder Drugs and Incident Dementia: A Population-based Case-control Study.
Topics: Aged; Canada; Case-Control Studies; Dementia; Humans; Muscarinic Antagonists; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive | 2022 |
[Assessment of prescribing practices in overactive bladder pharmacotherapy across different specialties of India: a prescription trend analysis].
Topics: Acetanilides; Humans; Muscarinic Antagonists; Prescriptions; Solifenacin Succinate; Tolterodine Tartrate; Urinary Bladder, Overactive; Urological Agents | 2023 |
Silicone adhesive, a better matrix for tolterodine patches-a research based on in vitro/in vivo studies.
Topics: Adhesives; Administration, Cutaneous; Animals; Benzhydryl Compounds; Biological Availability; Chemistry, Pharmaceutical; Cresols; Drug Delivery Systems; Male; Myristates; Phenylpropanolamine; Rabbits; Silicones; Skin; Skin Absorption; Tolterodine Tartrate; Transdermal Patch; Urinary Bladder, Overactive | 2012 |
Transdermal delivery of tolterodine tartrate for overactive bladder treatment: In vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Animals; Male; Rats, Sprague-Dawley; Skin Absorption; Tolterodine Tartrate; Transdermal Patch; Urinary Bladder, Overactive | 2017 |
Plasma concentration profile of tolterodine and 5-hydroxymethyl tolterodine following transdermal administration of tolterodine in rats.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Area Under Curve; Benzhydryl Compounds; Chromatography, Liquid; Cresols; Liquid-Liquid Extraction; Male; Muscarinic Antagonists; Rats; Rats, Sprague-Dawley; Tandem Mass Spectrometry; Tolterodine Tartrate; Transdermal Patch | 2018 |